Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Generic Drug Review: US FDA Approves More ANDAs Than It Receives For First Time Since Early 2016

Mar 09 2017

• By Derrick Gingery

pills

Related Content

Generic Drug First-Cycle Approval Rates Lagging Under GDUFA I

Oct 26 2016

Complex ANDAs To Be Allowed Pre-Submission Product Meetings

Oct 24 2016

Dark, Then Dawn: ANDA Workload Approaching Steady State After 2014 Eruption

Mar 28 2016

FDA's Generic Drug Workload, Productivity Beating Budget Estimates

Feb 22 2016

US Generic Reviews: Would Pre-Submission Meetings Be Better Than Six-Month Priority Review?

Mar 06 2017

ANDA Stress Test: End-Of-Year Submission Bolus Pressures US FDA Review System

Jan 09 2017

Generic Drug Review At US FDA: Has Submission Rush Ended Or Just Paused?

Feb 07 2017

Additional Topics

United States Generic Drugs Approvals Regulation FDA BioPharmaceutical

More from Generics

More from Biosimilars & Generics

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window